On November 11, 2025 TriSalus Life Sciences Inc. (Nasdaq: TLSI) ("TriSalus" or the "Company"), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, reported that Mary Szela, Chief Executive Officer and President, and David Patience, Chief Financial Officer, will participate in the following investor conferences in November:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Management will participate in one-on-one meetings and participate in a corporate overview on Thursday, November 20, at 2:30 p.m. ET. Click here for a link to the live webcast.
37th Annual Piper Healthcare Conference in New York, NY
Management will participate in one-on-one meetings and participate in a corporate overview on Tuesday, December 2, at 3:10 p.m. ET. Click here for a link to the live webcast.
A webcast replay of the corporate overview will be available for 90 days following the presentation in the Events section of the TriSalus Investor website at www.investors.trisaluslifesci.com.
(Press release, TriSalus Life Sciences, NOV 11, 2025, View Source [SID1234659766])